The prevalence of nonalcoholic steatohepatitis in Thai patients with non-HBV, non-HCV chronic hepatitis

Journal of the Medical Association of Thailand

Volumn 87, Issue SUPPL. 2, 2004, Pages

  Kladchareon, Nusont ^a   Treeprasertsuk, Sombat ^b   Mahachai, Varocha ^a   Wilairatana, Polrat ^c   Kullavanijaya, Pinit ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b Bangkok Hospital Medical Center   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Chronic hepatitis; Nonalcoholic steatohepatitis; Prevalence

Indexed keywords

ALCOHOL; ALKALINE PHOSPHATASE; FERRITIN; GLUCOSE;

ADULT; AGED; ALCOHOL CONSUMPTION; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; FERRITIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; INFLAMMATION; LIVER BIOPSY; LIVER FIBROSIS; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PREVALENCE; THAILAND;

ADULT; BODY MASS INDEX; COMORBIDITY; FATTY LIVER; FEMALE; HEPATITIS, CHRONIC; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; THAILAND;

EID: 22744438645     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, cheuer PJ. Classification of chronic hepatitis: Diagnosis, grading, and staging. Hepatology 1994; 19: 1513-20.
2. Suwanagool P. Hepatocellular carcinoma and cirrhosis in Thailand: etiological considerations of underlying cirrhosis. J Med Assoc Thai 1980; 63: 245-9.
3. Keating JJ, O'Brien CJ, Stellon AJ. Influence of etiology, clinical and histological features on survival in chronic active hepatitis: an analysis of 204 patients. Q J MED 1987; 237: 59-66.
4. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB, Homburger HA. The nature and prognosis of severe cryptogenic chronic active hepatitis. Gastroenterology 1993; 104: 1755-61.
5. Tanaka R, Itoshima T, Nagashima H. Follow-up study of 582 liver cirrhosis patients for 26 years in Japan (abstract). Liver 1987; 7: 316-24.
6. Bellentani S, Tiribelli C, Saccoccio G. Prevalence of chronic liver disease in the general population of northern Italy: The Dionysus Study. Hepatology 1994; 20: 1442-9.
7. Kodali VP, Gordon SC, Silverman AL, Mccray DG. Cryptogenic liver disease in the United States: further evidence for non-A, non-B, and non-C hepatitis. Am J Gastroenterol 1994; 89: 1836-9.
8. Levine RA, Ranek L. Asymptomatic chronic hepatitis, correlation between isolated serum transminase abnormality and liver biopsy. Gastroenterology 1970; 58: 371-8.
9. Zaman SN, Johnson PJ, Williums R. Silent cirrhosis in patients with hepatocellular carcinoma: implications for screening in high-incidence and low-incidence area. Cancer 1990; 65: 1607-10.
10. Oellerich M, Burdelski M, Lautz HU, Binder L, Pichlmayr R. Predictors of one year pretransplant survival in patients with cirrhosis. Hepatology 1991; 14: 1029-34.
11. Bac CD, Stroffolini T, Gaeta GB, Taliani G, Giusti G. Pathogenic factors in cirrhosis with and without hepatocellular carcinoma: A multicenter Italian study. Hepatology 1994; 20: 1225-30.
12. Koretz RL, Stone O, Gitnick GL. The long term course of non-Á, non B post-transfusion hepatitis. Gastroenterology 1980; 79: 893-8.
13. Koretz RL, Stone O, Mousa M. Non-A, non-B post transfusion hepatitis. A decade later. Gastroenterology 1985; 88: 1251-4.
14. Realdi G, Alberti A, Rugge M. Long term follow up of acute and chronic non A, non B post transfusion hepatitis. Evidence of progression to liver cirrhosis. Gut 1982; 23: 270-5.
15. Hul Crantz R, Glauman H, Lind berg G. Liver investigation in 149 patients with moderately elevated activities of serum transminases. Scan J Gastroenterol 1986; 21: 109-13.
16. Sriratanaban J. Abnormal liver enzymes in patients seeking physical check-up in the preventive clinic, Chulalongkorn Hospital. Chula Med J 1994; 38: 565-70.
17. Van Ness MM, Diehl AM. Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes? Ann Intern Med 1989; 111: 473-8.
18. Ludwig J. The nomenclature of chronic active hepatitis: An obituary. Gastroenterology 1993; 105: 274-8.
19. Friedman LS, Martin PL, Munoz SJ. Liver function tests and the objective evaluation of the patient with liver disease. In: Zakim D, Boyer TD, eds. Hepatology: A textbook of liver disease, 3 rd ed. Philadelphia: WB Saunders, 1996; 818-20.
20. Ludwig J, McGill DB, Lindor KD. Review: Nonalcoholic steatohepatitis. J Gastroenterol Hepatol 1997; 12: 398-403.
21. Berman M, Alter HJ, Ishak KG. The chronic sequelae of non-A, non B hepatitis. Ann Intern Med 1979; 91: 1-6.
22. Hay JE, Czaja AJ, Rakela J, Ludwig J. The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients. Hepatology 1989; 9: 193-7.
23. Sorbi D, Boynton J, Lindor KD. The ratio of aspartate aminotransferase to alanine aminotransferase: Potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am J Gastroenterol 1999; 94: 1018-22.
24. Powell EE, Cooksley WGE, Hanson R, Searll J, Halliday JW, Powell LW. The natural history of Nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years. Hepatology 1990; 11: 74-80.
25. Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med 1997; 126: 137-5.
26. Rogers DW, Lee CH, Pound DC. Hepatitis C does not cause nonalcoholic steatohepatitis. Dig Dis Sci 1992; 37: 1644-7.
27. Alter H, Purcell RH, Shih JW. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non B hepatitis. N Engl J Med 1989; 321: 1494-500.
28. Hagiward H, Hayashi N, Mita E. Detection of hepatitis C virus RNA in Chronic non-A, non-B liver disease. Gastroenterology 1992; 102: 692-4.
29. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Teri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994; 107: 1103-9.
30. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors. Hepatology 1990; 12: 1106-10.
31. Younossi ZM, Matteoni CI, Gramlisch T. Patient characteristics predicting cirrhosis and death in non alcoholic steatohepatitis. Hepatology 1998; 28: 303A.
32. James O. Non alcoholic steatohepatitis: another disease of affluence. Lancet 1999; 353: 1634-6.
33. Matteoni CA, Younossi ZM, Gramlich T. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116: 1413-9.
34. Satyagit D, Tamir BM, Gopikrishmon V, Chan KM, Mark B. Prospective evaluation of unexplained chronic liver transminase abnormalities in asymptomatic and symptomatic patients. Am J Gastroenterol 1999; 94: 3010-4.
35. Angelucci E, Baronciani D, Lucarelli G, et al. Needle liver biopsy in Thalassemia: analyses of diagnostic accuracy and safety in 1184 consecutive biopsies. Br J Haematol 1995; 89: 757-61.
36. Younossi ZM, Teran JC, Ganiats TG, Carey WD. Ultrasound-guided liver biopsy for parenchymal liver disease: An economic analysis. Dig Dis Sci 1998; 43: 46-50.
37. James OFW, Day CP. Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. J Hepatology 1998; 29: 495-501.
38. Knobler H, Schattner A, Zhornicki T, et al. Fatty liver-an additional and treatable feature of the insulin resistance syndrome. Q J Med 1999; 92: 73-9.
39. Bass NM. Three for the price of one knockout-a mouse model of congenital peroxisomal disorder, steatohepatitis and hepatocarcinogenesis. Hepatology 1999; 29: 606-7.